(3, S). The experimental design was as follows (Fig. 1) . Bone marrow cells from normal rabbits with the allotype A1, A4 (or A2, A4, A~) were injected intravenously into normal rabbits with the allotype A~, A4 (or Ax, AO which had just been subjected to 800 R total body irradiation. The recipient rabbits were then also injected with 109 SRBC intravenously.
Seven days following cell transfer, the recipient rabbits were sacrificed by intravenous Nembutal, 50 rag. per kg body weight, and the spleen cells were analyzed for their capacity to produce direct plaques by the technique of Jerne et ai (6, 7) , with slight modifications (5) . The spleen cells were incubated with anfi-ailotype antiserum (anti-A1 or anti-A~) or normal rabbit serum (N'RS) and SRBC in the agar phase prior to the addition of complement. The antisera and NRS were all diluted in a 1% solution of human serum albumin (Hyland Laboratories, Los Angeles, Calif.). The technique is essentially that described by Chou et al (8) . The results are expressed as the number of plaques per 106 spleen ceils incubated.
Normal rabbit bone marrow cells were also either heat-killed by incubation in a 60°C water bath for I hr, or sonicated using an ultrasonic disintegrator (Fisher Ultrasonic Probe) at 16,000 cycles per second for 1 win. These preparations were injected into rabbits which had just been subjected to a dose of 800 R total body irradiation. The recipients were also given * Recipients were subjected to 800 R total body irradiation prior to the intravenous administration of the bone marrow and the SRBC (109 cells).
Each value represents the mean of duplicate determinations; the values did not normally vary by more than +10% from the mean.
109 SRBC via the intravenous route. 7 days later, the animals were sacrificed and the spleen cells analyzed for plaque-forming capacity as described above.
RESULTS
As can be seen in Table I , spleen cells of irradiated rabbits injected with SRBC and normal homologous bone marrow cells formed many plaques in vitro, whereas spleen cells d irradiated recipients given SRBC and primed homologous bone marrow cells obtained from a donor rabbit injected with SRBC 24 hr prior to sacrifice were unable to produce plaques in vitro. The data have been presented previously (4, 5) , but they are reproduced here in order to facilitate the interpretation of the subsequent data. * Recipients were subjected to 800 R total body irradiation prior to the intravenous administration of the bone marrow and the SRBC (109 cells).
:~ Each value represents the mean of duplicate determinations; the values did not normally vary by more than -4-10% from the mean. * Recipients were subjected to 800 R total body irradiation prior to the intravenous administration of the bone marrow and the SRBC (109 cells).
Each value represents the mean of duplicate determinations; the values did not normally vary by more than -4-10% from the mean.
As can be seen in Tables II and III , incubation of spleen cells with SRBC and anti-allotype antiserum directed to the recipient genotype completely inhibited subsequent plaque formation after the addition of complement. However, incubation of the spleen cells with anti-donor allotype antiserum or NRS had no inhibitory effect on the plaque-forming ability of the spleen cells. The entire experiment was repeated four times with essentially similar results.
As can be seen in Table IV , spleen cells of irradiated rabbits which had been injected with normal rabbit bone marrow cells gave many plaques, whereas spleen cells of irradiated rabbits which had been injected with either the heatkilled or sonicated preparations of the bone marrow did not give a greater than background number of plaques.
Insofar as the viability of these two latter cell preparations, prior to their administration into irradiated recipients, is concerned, no intact cell could be observed in the sonicate prepared from 0.5 X 10 ~ cells. Using the dye exclusion test as an indicator of viability, less than 5 % of the cells in the heat-killed preparation were viable.
DISCUSSION
Whether the antibody-forming capacity of an irradiated recipient animal which had been injected with homologous bone marrow or lymphoid cells is of donor and/or recipient origin is a question which has intrigued immunologists for several decades. However, the resolution of this problem has been difficult in view of the inability of the investigator to distinguish between the donor and recipient cells on a morphological or functional basis. The recent demonstrations by Oudin (9-12), Dray et al (13) (14) (15) (16) , Sell (17), Dubiski et al (18) (19) (20) , and Chou et al. (21) that outbred rabbits can be distinguished from each other on the basis of antigenically dissimilar immunoglobulin molecules (22) suggested a specific immunologic approach to the problem. In fact, Sell and Gell (23, 24) have already verified the potential immunological nature of such a system by demonstrating the induction of blastogenesis and mitosis in lymphocyte cultures incubated with specific anti-ailotype antiserum. Chou et al. (21) transferred various antigen-sensitized lymphoid cells to neonatal recipient rabbits and concluded that the antibody-forming cell in the neonatal host was of recipient origin, and not of donor origin. Antibodies in the circulation of the recipient were purified by the use of specific immunoabsorbents and were found to react only with anti-recipient allotype antiserum in vitro and not with anti-donor allotype antiserum. Nevertheless, immunoglobulins other than antibodies were found to be of donor cell origin. These investigators were unable to satisfactorily explain this dichotomy in their results. Mitchell and Miller (25, 26) , using the irradiated mouse as the recipient animal and the hemolytic plaque technique as the means of assay of immunologic activity, arrived at the same conclusion with respect to the recipient origin of the antibody-forming cell. They observed that the plaques could be inhibited only by incubation of the spleen cells with anti-recipient lymphocyte antiserum and not with antiserum directed to donor lymphocytes. Results of a conflicting nature have been obtained by Harris et al. (27) (28) (29) . They observed that the immune response to Shigella in the irradiated recipient mouse could be inhibited by prior immunization of the prospective recipient with donor white cells. They have also observed that in vitro plaque formation by spleen cells of one strain of mice could be inhibited by incubation of these cells with antiserum directed to these cells produced in another strain of mice (30) . They also transferred rabbit lymph node cells of one allotype, after in vitro incubation with Shigella antigen, into irradiated rabbits of a different allotype (31) .
The antibodies detected in the circulation of the recipients were demonstrated to be of donor, not recipient, origin. They therefore concluded that antibody formation is a property of the donor cells transferred to the irradiated recipient. Our results using the rabbits are consistent with those of Mitchell and Miller (25, 26) and Chou et al. (21) in that they unequivocally demonstrate the host origin of the antibody-forming cell. Plaque formation was inhibited when spleen cells of irradiated recipients injected with allogeneic normal bone marrow and sheep erythrocytes were incubated with antiserum directed to the recipient allotype prior to the addition of complement to the plates. No inhibition was obtained when the spleen ceils were incubated with either anti-donor aUotype antiserum or normal rabbit serum.
One possible explanation for the lack of correlation between our results, those of Mitchell and Miller (25, 26) , and Chou et al. (21) , on the one hand, and those of Harris et al. (27) (28) (29) (30) (31) , on the other, may be related to the type of antigen used. The latter have used the Shigella as antigen and have assumed that the immune response induced with it is a primary one. However, in all likelihood, the donor as well as the recipient animals may have come into contact with Shigella antigens prior to the initiation of the experiment. Thus, the rabbit lymph node cells incubated with antigen and transferred to an irradiated recipient are, in fact, antibody-forming cells capable by themselves of initiating a secondary immune response in the irradiated recipient. On the other hand, the immune responses induced by sheep red cells and human serum proteins as antigens can be considered to be of a primary type.
It has been shown that primed bone marrow, which is defined as bone marrow obtained from rabbits 24 hr after administration of the antigen, is incapable of conferring antibody-forming capacity to irradiated recipients with respect to the antigen injected into the donor rabbit (4, 5) and the interpretation offered is that the antigen-reactive cell, normally a resident in the bone marrow, rapidly vacates the bone marrow after contact with the antigen in vivo. This hypothesis, that normal bone marrow contains the antigen-reactive ceils, necessitates the additional assumption that theirradiatedrecipient still lmssesses the antibody-formlng cells. It was this latter hypothesis that was tested in the current investigation.
It was demonstrated that spleen cells of irradiated recipient rabbits which were injected with normal rabbit bone marrow cells and antigen (SRBC) gave many plaques in vitro. However, if the spleen cells were incubated with antiserum directed to recipient allotype, plaque formation was inhibited whereas incubation of the spleen cells with antiserum directed to donor allotype had no inhibitory effect on the number of plaques formed. Since identical results were achieved with both the normal and converse situations (donor A1, A4 into recipient A2, A4, A5 and donor A1, A2, A~ into recipient Ai, A4), it may be concluded that the inhibitory effects of the anti-allotype antiserum are specific and that the antibody-forming cell in the irradiated animal is of recipient, and not donor, origin.
It is interesting to note that neither "nonspecific" inhibition nor "specific enhancement" of plaque formation by the anti-allotype antisera were observed in this investigation, although the antisera were used in varying dilutions. It has been reported that anti-allotype antiserum may, at certain concentrations, enhance the number of plaques when incubated with the cells to which it is directed (8, 52) . However, incubation of the antibody-forming cells with the diluted anti-allotype antiserum generally results in an inhibition of plaque formation (8, 53, 54) . It has also been reported that certain antisera possess nonspecific inhibitory activity in that they can inhibit plaque formation even if incubated with cells of a different allotype. ~ These considerations must be taken into account and adequate controls must be performed in order to ensure correct interpretation of data obtained in experiments using anti-allotype antisera as markers.
It was demonstrated that viable bone marrow cells are required in the transfer of antibody-forming capacity to irradiated recipients. Neither sonicates nor heat-killed preparation of normal rabbit bone marrow were capable of transferring antibody-forming activity. These findings, therefore, rule out any "adjuvant" effect by transferred cells, be they viable or not, and also rule out the possibility that cell extracts or cell-free preparations could transfer antibody-forming capacity or "information" to be subsequently taken up by host cells in a fashion similar to the totally in vitro system described by Fishman (36) and Adler et al. (37) .
Since the antibody-forming cell was demonstrated to be of recipient origin, one must necessarily assume that it is radioresistant to 800 R and that it is the antigen-reactive cell which is radiosensitive. This interpretation is supported by the following findings: (a) the irradiated rabbits given 800 R irradiation, and injected with SRBC only, fail to exhibit an immune response (5); (b) the number of plaque-forming cells in the spleen of an irradiated recipient of normal allogeneic bone marrow cells is similar to the number observed in the spleen of a normal immunized rabbit (5); and (c) the bone marrow cells of irradiated rabbits lose their capacity to react with antigens in vitro and are incapable of transferring antibody-forming capacity to irradiated recipient allogeneic rabbitsY Experiments performed by Harris et al. (32) more than a decade ago also support our concept of the cellular events occurring during the primary immune response. They observed that the transfer of cells of the popliteal lymph node of a rabbit injected 3 days previously with Shigella antigen into normal or X-irradiated recipients resulted in the formation of antibodies. However, if the recipients were irradiated within 1 hr after receiving the primed lymph node cells, the immune response was markedly suppressed in comparison with that in a nonirradiated control. These results suggest that the immunologically important cell transferred is an irradiation-sensitive antigen-reactive cell, which had migrated out of the bone marrow to the peripheral lymphoid tissues. A scheme depicting the interrelationship of these two cell types in the induction of the primary immune response in the rabbit is presented in Fig. 2 .
A question which requires consideration is whether one can define the induction of the primary response as a result of a two-cell interaction, the antigenreactive and antibody-forming cells (25, 26, (33) (34) (35) , or whether it is necessary to postulate a third cell-type, the macrophage. The evidence favoring an eminent role for the macrophage in the induction of the immune response has been well documented and has accrued from both in vitro and in vivo investigations (36) (37) (38) (39) (40) (41) (42) . However, the exact stage in the immune response where the macrophage acts has hitherto not been precisely stated or defined. Evidence of a three-cell interaction has been presented by Mosier and Coppleson (43) , Pribnow and Silverman (44) and Gallily and Feldman (45) . Pribnow and Silverman (44) have demonstrated that the interaction of the antigen with macrophage is the initial cellular event in the induction of the primary immune response. They observed that irradiated rabbits that received nonimmune lymph node cells and peritoneal macrophages which had been incubated with the antigen in vitro were unable to form antibody whereas normal recipients of these cells exhibited a typical primary immune response. The transfer of antigen-incubated lymph node cells, in the absence of macrophages, failed to elicit an immune response in either normal or irradiated rabbits. Furthermore, macrophages which had been irradiated after their incubation with the antigen were unable to initiate an immune response when transferred to normal recipients. The findings of Gallily and Feldman (45) also strongly imply a three-cell system. They observed that normal macrophages of mice incubated with Shigella antigen and transferred to mice previously exposed to 550 R were able to initiate an immune response in the recipient, whereas there was no immune response with antigen alone. However, the immune response was suppressed if the recipient mice had been subjected to 900 R irradiation. Furthermore, macrophages from irradiated donors, incubated with Shigella, were incapable of inducing antibody formation in irradiated recipients.
On the basis of our results, these data imply that the antigen-reactive cell in the recipient, whose functions in the immune response commence after the macrophage-antigen interaction, is irradiation-sensitive to 900 R but not to 550 R in both the mouse and the rabbit. However, it would not appear to be as irradiation-sensitive as the macrophage which is inactivated by 550 R irradiation. Therefore, the sequential transfer of immunologic information leading to the initiation of the immune response--macrophage to antigen-reactive cell to antibody-forming cell--is broken after irradiation.
In summary, we have demonstrated that the antibody-forming cells in irradiated rabbits which had received allogeneic bone marrow cells and antigen are of recipient origin and that they are relatively irradiation-resistant. These results, as well as those of other investigators, also suggest that it is the antigen-reactive cell which is irradiation-sensitive and that a third cell, the irradiation-sensitive macrophage, must be incorporated into the scheme of cell interactions leading up to antibody formation in the primary immune response (Fig. 2) . Although it has been demonstrated that the bone marrow in the rabbit serves as a prime source of antigen-reactive cells (4, 5) and macrophages (46) (47) (48) , and that in the rodent the cell mediating humoral and cellular immunity appears to originate in the bone marrow (25, (49) (50) (51) , the organ(s) of origin of the antibody-forming cell(s) in the rabbit still remains to be determined.
SUMMARY"
Bone marrow cells obtained from rabbits of one allotype were injected into irradiated rabbits of a different allotype. The recipients were also injected with sheep red blood cells, and their spleen cells were tested for plaque-forming capacity 7 days later. Spleen cells of all recipients gave large numbers of plaques as did spleen cells incubated with antiserum directed toward donor allotype. However, incubation of the recipient spleen cells with antiserum directed toward recipient allotype completely suppressed plaque formation. These results demonstrate that antibody-formation in irradiated recipients of transferred lymphoid cells is a property of the recipient animal and that the antibodyforming cell is relatively irradiation-resistant.
I t was also demonstrated that only viable normal bone marrow cells are capable of transferring antibody-forming capacity to irradiated recipient rabbits. Neither sonicates nor heat-killed preparations of normal rabbit bone marrow cells possessed this capacity.
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